some say virbac spent $500K on a "cheap and nasty" trial and walked away because "they didn’t get the desired results". Not sure what the required results would have been for virbac apart from this product has commercial potential ...........
and no reason why trial was halted and product NOT given to alternative tester and focus of product quickly turned from open-field to grain silos.
Happy to trade the trade, happy to buy on movement, happy to manage my capital while reviewing the facts, happy to jump back in on good ann's.
